Publication | Closed Access

A combination of oral endothelin-areceptor antagonist and oral prostacyclinanalogue is superior to each drug alone inameliorating pulmonary hypertension in rats

HypertensionOral Endothelin-areceptor AntagonistPulmonary Arterial HypertensionPulmonary CirculationMedicinePhysiologyOral ProstacyclinanaloguePulmonary PharmacologyPulmonary HypertensionVascular BiologyPharmacotherapyPublic HealthPharmacologyPulmonary Vascular Disease